Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status

Author

NISHIHARA, Reiko^{1 4} ; LOCHHEAD, Paul^{1 7} ; SPIEGELMAN, Donna^{2 5 6} ; EUNYOUNG CHO² ; GIOVANNUCCI, Edward^{2 4 5} ; FUCHS, Charles S^{1 2} ; CHAN, Andrew T^{2 9} ; SHUJI OGINO^{1 3 5} ; KUCHIBA, Aya^{1 4} ; SEUNGYOUN JUNG² ; MAI YAMAUCHI¹ ; XIAOYUN LIAO¹ ; YU IMAMURA¹ ; ZHI RONG QIAN¹ ; MORIKAWA, Teppei^{1 8} ; MOLIN WANG^{2 5 6}
[1] Department of Medical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, United States
[2] Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, United States
[3] Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, United States
[4] Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, United States
[5] Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States
[6] Department of Bio-statistics, Harvard School of Public Health, Boston, Massachusetts, United States
[7] Gastrointestinal Research Group, Institute of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, United Kingdom
[8] Department of Pathology, University of Tokyo Hospital, Tokyo, Japan
[9] Division of Gastroenterology, Massachusetts General Hospital, Boston, United States

Source

JAMA, the journal of the American Medical Association. 2013, Vol 309, Num 24, pp 2563-2571, 9 p ; ref : 43 ref

ISSN

0098-7484

Scientific domain

General medicine general surgery

Publisher

American Medical Association, Chicago, IL

Publication country

United States

Document type

Article

Language

English

Keyword (fr)

Acide acétylsalicylique Analgésique Antiinflammatoire non stéroïde Antipyrétique Cancer colorectal Facteur risque Gène onc cellulaire Génétique Inhibiteur thromboagrégation Mutation Médecine Protooncogène Risque Utilisation Gène BRAF Cancer Enzyme Inhibiteur enzyme Oxidoreductases Pathologie de l'appareil digestif Pathologie de l'intestin Pathologie du côlon Pathologie du rectum Prostaglandin-endoperoxide synthase Salicylés Tumeur maligne

Keyword (en)

Acetylsalicylic acid Analgesic Non steroidal antiinflammatory agent Antipyretic Colorectal cancer Risk factor C-Onc gene Genetics Antiplatelet agent Mutation Medicine Protooncogene Risk Use BRAF Gene Cancer Enzyme Enzyme inhibitor Oxidoreductases Digestive diseases Intestinal disease Colonic disease Rectal disease Prostaglandin-endoperoxide synthase Salicylates Malignant tumor

Keyword (es)

Acetilsalicilico ácido Analgésico Antiinflamatorio no esteroide Antipirético Cancer de colon y recto Factor riesgo Gen onc celular Genética Inhibidor tromboagregación Mutación Medicina Protooncogen Riesgo Uso Gen BRAF Cáncer Enzima Inhibidor enzima Oxidoreductases Aparato digestivo patología Intestino patología Colón patología Recto patología Prostaglandin-endoperoxide synthase Salicilatos Tumor maligno

Classification

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B01 General aspects

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04C Multiple tumors. Solid tumors. Tumors in childhood (general aspects)

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B01 Tumors

Discipline

Gastroenterology. Liver. Pancreas. Abdomen Generalities in medical sciences Tumours

Origin

Inist-CNRS

Database

PASCAL

INIST identifier

27504691

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS